Jonathan E. Freeman

Jonathan E. Freeman has an extensive background in the biopharmaceutical and healthcare investment sectors. Notable roles include serving as Senior Vice President of Strategy & Global Portfolio Management at EMD - Affiliates of Merck KGaA, and as Chief Business Officer at Vedanta Biosciences, Inc. Jonathan founded and currently operates as Chief Operating Officer at Anthos Therapeutics, while also acting as an advisor at Clarus Funds and as an Operating Advisor at Blackstone. Jonathan holds board positions at GRIN Therapeutics, Inc. and Neurvati Neurosciences. Educational credentials include a Master of Arts in Natural Sciences from the University of Cambridge and a PhD from The University of Edinburgh.